18 withdrawn. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Withdrawn 18 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-antibiotic Management in Acute Uncomplicated Diverticulitis Symptomatic treatment (ibuprofen and acetaminophen), Amoxicillin-clavulanate, Ciprofloxacin plus metronidazole - Acute Uncomplicated Diverticulitis | Phase 4 | Withdrawn | Montefiore Medical Center | 2026-07-01 | 2026-08-31 | |
| Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications Adjuvanted Recombinant Zoster Vaccine (RZV) - Inflammatory Bowel Diseases, IBD | Phase 4 | Withdrawn | University of Wisconsin, Madison | 2024-10-01 | 2024-09-25 | |
| Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study Ozanimod Oral Capsule - Ulcerative Colitis | Phase 4 | Withdrawn | Geert D'Haens | 2024-08-01 | 2024-09-19 | |
| Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients Infliximab, Exclusive Enteral Nutrition - Crohn's Disease, Exclusive Enteral Nutrition | Phase 4 | Withdrawn | Children's Hospital of Fudan University | 2022-10-01 | 2022-08-09 | |
| Bezlotoxumab Versus FMT for Multiple Recurrent CDI Bezlotoxumab, Fecal Microbiota Transplantation (FMT), Vancomycin oral - Clostridium Infections, Clostridioides Difficile | Phase 4 | Withdrawn | Leiden University Medical Center | 2022-01-01 | 2023-03-28 | |
| Once Daily Metronidazole for Perforated Appendicitis Metronidazole - Appendicitis | Phase 4 | Withdrawn | Ahmed Nasr | 2019-01-01 | 2017-07-21 | |
| Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD Adalimumab - Crohn Disease, Ulcerative Colitis | Phase 4 | Withdrawn | McMaster University | 2018-02-01 | 2020-01-18 | |
| An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis Vedolizumab - Ulcerative Colitis | Phase 4 | Withdrawn | University of Pennsylvania | 2017-07-01 | 2019-07-08 | |
| Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis berberine, regular treatment - Ulcerative Colitis | Phase 4 | Withdrawn | Xijing Hospital of Digestive Diseases | 2016-11-01 | 2023-02-01 | |
| Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole Trimebutine Maleate, rabeprazole - Refractory Reflux Esophagitis | Phase 4 | Withdrawn | Xijing Hospital of Digestive Diseases | 2016-11-01 | 2023-02-01 | |
| Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study Caffeine, Losartan, Omeprazole - Colitis, Ulcerative, Crohn Disease | Phase 4 | Withdrawn | Takeda | 2016-11-01 | 2020-10-27 | |
| Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF vedolizumab - Crohn Disease | Phase 4 | Withdrawn | Universita degli Studi di Genova | 2016-09-01 | 2018-05-14 | |
| Thiopurine Induced Pancreatitis in IBD Patients Azathioprine - Pancreatitis, Inflammatory Bowel Diseases | Phase 4 | Withdrawn | Shaare Zedek Medical Center | 2015-03-01 | 2021-03-18 | |
| Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Adalimumab - Spondyloarthritis, Crohn's Disease | Phase 4 | Withdrawn | University of Alberta | 2009-07-01 | 2016-09-16 | |
| Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy natalizumab - Crohn's Disease | Phase 4 | Withdrawn | Biogen | 2008-12-01 | 2016-06-16 | |
| Addition of Lactobacillus to Metronidazole in Treatment of CDAD Lactobacillus GG - Enterocolitis, Pseudomembranous Colitis | Phase 4 | Withdrawn | Michael E. DeBakey VA Medical Center | 2008-08-01 | 2017-05-10 | |
| Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease Colecalciferol D3 (Vigantol Oil), Medium chain triglycerides - Crohn's Disease | Phase 4 | Withdrawn | Imperial College London | 2008-05-01 | 2015-06-08 | |
| Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Rifabutin, Clarithromycin, and Clofazimine - Crohn's Disease | Phase 4 | Withdrawn | Medstar Health Research Institute | 2007-07-01 | 2020-08-20 |
Crohn Disease (9) · Colitis, Ulcerative (6) · Inflammatory Bowel Diseases (3) · Enterocolitis, Pseudomembranous (2) · Acute Disease (1) · Appendicitis (1) · Arthritis, Rheumatoid (1) · Clostridium Infections (1) · Diverticulitis, Colonic (1) · Enterocolitis (1) · Esophagitis, Peptic (1) · Pancreatitis (1) · Spondylarthritis (1) · Spondylitis, Ankylosing (1)
Digestive System Diseases (18) · Gastrointestinal Diseases (18) · Intestinal Diseases (18) · Inflammatory Bowel Diseases (10) · Colonic Diseases (7) · Colitis (6) · Infections (3) · Arthritis (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Ankylosis (1)
vedolizumab (3) · Adalimumab (2) · Metronidazole (2) · Acetaminophen (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Azathioprine (1) · Berberine (1) · Caffeine (1) · Calcium (1) · Cholecalciferol (1) · Ciprofloxacin (1) · Clarithromycin (1) · Clofazimine (1) · Dextromethorphan (1) · Fecal Microbiota Transplantation (1)
Xijing Hospital of Digestive Diseases (2) · Ahmed Nasr (1) · Biogen (1) · Children's Hospital of Fudan University (1) · Geert D'Haens (1) · Imperial College London (1) · Leiden University Medical Center (1) · McMaster University (1) · Medstar Health Research Institute (1) · Michael E. DeBakey VA Medical Center (1) · Montefiore Medical Center (1) · Shaare Zedek Medical Center (1) · Takeda (1) · Universita degli Studi di Genova (1) · University of Alberta (1)
United States (4) · Canada (1) · China (1) · Israel (1) · Netherlands (1) · United Kingdom (1)
Ahmed Nasr (1) · Ailsa L Hart, BA(Hons), BM BCh, MRCP, PhD (1) · Andrew N Milestone, BSc(Hons) MBBS MRCP (1) · Daniel M Musher, M.D. (1) · Freddy Caldera, DO, MS (1) · Geert DHaens (1) · J van Prehn (1) · James Taylor, MD (1) · Nabeel Khan, MD (1) · Oren Ledder, MD (1) · Subrata Ghosh, MD (Edin) FRCP, FRCP (Edin) (1) · Timothy R Koch, MD (1) · Walter P Maksymowych, FRCP(C) (1) · Ying Huang, Dr (1)
2023 (1), 2025 (1)